Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Efficacy of the PanCareFollowUp eHealth Lifestyle Intervention for Survivors of Childhood, Adolescent and Young Adult Cancer

SR. van den Oever, E. Bouwman, HJH. van der Pal, PC. Steensma, V. Araujo-Soares, M. Brown, T. Kepak, K. Kepakova, M. Fiocco, LMM. Fremouw, MMW. Koopman, RRL. van Litsenburg, P. van der Torre, J. Wilbers, R. Skinner, LCM. Kremer, J. Loonen, SMF....

. 2025 ; 14 (5) : e70694. [pub] -

Language English Country United States

Document type Journal Article

Persistent link   https://www.medvik.cz/link/bmc25009619

Grant support
824982 European Commission

PURPOSE: A healthy lifestyle may prevent or mitigate late effects in childhood, adolescent and young adult (CAYA) cancer survivors. To support survivors in adopting healthier behaviours, the PanCareFollowUp (PCFU) Lifestyle intervention was developed, encompassing 4 months of online lifestyle coaching aimed at achieving a personal lifestyle goal. The aims of this study were to (1) determine the efficacy of this intervention on lifestyle outcomes over time and (2) identify predictors for goal achievement. PATIENTS AND METHODS: Fifty-eight survivors were enrolled. Outcomes were assessed at baseline (T0), after 4 months of coaching (T1) and after 4 months of follow-up (T2). The primary outcome included the percentage of survivors successful in achieving and sustaining their goal, whereas secondary outcomes included differences in body mass index (BMI), diet and physical activity. To evaluate the adjusted, longitudinal effects on secondary outcomes, linear mixed models were estimated. Predictors for goal achievement were identified through logistic regression analysis. RESULTS: At T1 and T2, 68% and 76% of goals were achieved or sustained, respectively. Mean differences between T2 and T0 showed significant improvements in BMI (-0.5 kg/m2), diet (-0.6 points) and physical activity (+7.7 h/week). Estimation of multivariable models also showed positive effects. Participants with a lower BMI and fewer depressive feelings at baseline were more likely to achieve and/or sustain their goals at T2. CONCLUSION: Findings suggest that the PCFU Lifestyle intervention supports survivors in making lifestyle changes. Results can be used to inform a subsequent randomised intervention study and integrate lifestyle coaching into care. TRIAL REGISTRATION: International Clinical Trial Registry Platform (ICTRP) number: NL8932 (ICTRP Search Portal [who. int]). Registered on 29 September 2020.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25009619
003      
CZ-PrNML
005      
20250429135257.0
007      
ta
008      
250415s2025 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1002/cam4.70694 $2 doi
035    __
$a (PubMed)40019031
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a van den Oever, Selina R $u Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands $1 https://orcid.org/0000000262273472
245    10
$a Efficacy of the PanCareFollowUp eHealth Lifestyle Intervention for Survivors of Childhood, Adolescent and Young Adult Cancer / $c SR. van den Oever, E. Bouwman, HJH. van der Pal, PC. Steensma, V. Araujo-Soares, M. Brown, T. Kepak, K. Kepakova, M. Fiocco, LMM. Fremouw, MMW. Koopman, RRL. van Litsenburg, P. van der Torre, J. Wilbers, R. Skinner, LCM. Kremer, J. Loonen, SMF. Pluijm, PanCareFollowUp consortium
520    9_
$a PURPOSE: A healthy lifestyle may prevent or mitigate late effects in childhood, adolescent and young adult (CAYA) cancer survivors. To support survivors in adopting healthier behaviours, the PanCareFollowUp (PCFU) Lifestyle intervention was developed, encompassing 4 months of online lifestyle coaching aimed at achieving a personal lifestyle goal. The aims of this study were to (1) determine the efficacy of this intervention on lifestyle outcomes over time and (2) identify predictors for goal achievement. PATIENTS AND METHODS: Fifty-eight survivors were enrolled. Outcomes were assessed at baseline (T0), after 4 months of coaching (T1) and after 4 months of follow-up (T2). The primary outcome included the percentage of survivors successful in achieving and sustaining their goal, whereas secondary outcomes included differences in body mass index (BMI), diet and physical activity. To evaluate the adjusted, longitudinal effects on secondary outcomes, linear mixed models were estimated. Predictors for goal achievement were identified through logistic regression analysis. RESULTS: At T1 and T2, 68% and 76% of goals were achieved or sustained, respectively. Mean differences between T2 and T0 showed significant improvements in BMI (-0.5 kg/m2), diet (-0.6 points) and physical activity (+7.7 h/week). Estimation of multivariable models also showed positive effects. Participants with a lower BMI and fewer depressive feelings at baseline were more likely to achieve and/or sustain their goals at T2. CONCLUSION: Findings suggest that the PCFU Lifestyle intervention supports survivors in making lifestyle changes. Results can be used to inform a subsequent randomised intervention study and integrate lifestyle coaching into care. TRIAL REGISTRATION: International Clinical Trial Registry Platform (ICTRP) number: NL8932 (ICTRP Search Portal [who. int]). Registered on 29 September 2020.
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a mladiství $7 D000293
650    12
$a přežívající onkologičtí pacienti $x psychologie $7 D000073116
650    _2
$a mladý dospělý $7 D055815
650    12
$a telemedicína $7 D017216
650    12
$a cvičení $7 D015444
650    _2
$a dítě $7 D002648
650    _2
$a zdravý životní styl $7 D000070497
650    _2
$a nádory $x terapie $x psychologie $7 D009369
650    _2
$a dospělí $7 D000328
650    _2
$a index tělesné hmotnosti $7 D015992
650    _2
$a životní styl $7 D008019
655    _2
$a časopisecké články $7 D016428
700    1_
$a Bouwman, Eline $u Radboud University Medical Centre, Nijmegen, the Netherlands $1 https://orcid.org/0000000291499745
700    1_
$a van der Pal, Helena J H $u Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands
700    1_
$a Steensma, Philippa C $u Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands
700    1_
$a Araujo-Soares, Vera $u Center for Preventive Medicine and Digital Health, Medical Faculty Mannheim, Heidelberg University, Heidelberg, Germany
700    1_
$a Brown, Morven $u Wolfson Childhood Cancer Research Centre, Newcastle, UK
700    1_
$a Kepak, Tomas $u International Clinical Research Center, St. Anne's University Hospital Brno, Brno, Czech Republic
700    1_
$a Kepakova, Katerina $u International Clinical Research Center, St. Anne's University Hospital Brno, Brno, Czech Republic
700    1_
$a Fiocco, Marta $u Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands $u Mathematical Institute Leiden University, Leiden, the Netherlands $u Department of Biomedical Data Science, Section Medical Statistics, Leiden University Medical Center, Leiden, the Netherlands
700    1_
$a Fremouw, Lucy M M $u Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands
700    1_
$a Koopman, Maria M W $u Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands
700    1_
$a van Litsenburg, Raphaële R L $u Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands
700    1_
$a van der Torre, Patrick $u Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands
700    1_
$a Wilbers, Joyce $u Radboud University Medical Centre, Nijmegen, the Netherlands
700    1_
$a Skinner, Roderick $u Great North Children's Hospital, and Translational and Clinical Research Institute, and Centre for Cancer, Newcastle University, Newcastle, UK $1 https://orcid.org/000000021162675X
700    1_
$a Kremer, Leontien C M $u Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands $u University Medical Center Utrecht, Wilhelmina Children's Hospital, Utrecht, the Netherlands
700    1_
$a Loonen, Jacqueline $u Radboud University Medical Centre, Nijmegen, the Netherlands
700    1_
$a Pluijm, Saskia M F $u Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands
710    2_
$a PanCareFollowUp consortium
773    0_
$w MED00181704 $t Cancer medicine $x 2045-7634 $g Roč. 14, č. 5 (2025), s. e70694
856    41
$u https://pubmed.ncbi.nlm.nih.gov/40019031 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250415 $b ABA008
991    __
$a 20250429135252 $b ABA008
999    __
$a ok $b bmc $g 2311161 $s 1246700
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2025 $b 14 $c 5 $d e70694 $e - $i 2045-7634 $m Cancer medicine $n Cancer Med $x MED00181704
GRA    __
$a 824982 $p European Commission
LZP    __
$a Pubmed-20250415

Find record

Citation metrics

Archiving options